Medical device and AI company, OPUM, and orthopedic bracing manufacturer, Thuasne Group, have signed a partnership on a digital solution for non-invasive non-pharmacological treatment of osteoarthritis (OA).
The partnership’s focus is to digitize musculoskeletal care by using objective data, determining the best treatment methods for OA to improve patient outcomes and reduce overall costs. The first product will integrate OPUM’s AI-enabled Digital Knee® care platform with Thuasne’s Rebel® Reliever OA knee brace. Together the technologies will deliver personalized exercise and behavioral therapies direct to the patient while allowing remote monitoring at scale so clinicians can manage more patients with a higher quality of personalized care.
“We are thrilled to announce this partnership with OPUM which will be harnessing the power of our flagship Rebel® Reliever OA knee brace and our trusted Townsend Motion hinge. Combining emerging digital solutions with industry-leading technology is an exciting prospect and we look forward to the opportunities ahead,” says Matthieu Ducottet, Innovation Director Thuasne Group.
“This partnership is a key part of our vision to deliver scalable personalized musculoskeletal care to positively impact the lives of patients around the world. Our solution spans the joint health continuum helping guide patients, and their providers, from initial onset through optimally prescribed interventions to reach their goals,” says OPUM CEO Prof. Andrew McDaid.
The Digital Knee® Rebel Reliever is currently deployed at the Shirley Ryan AbilityLab (ranked #1 rehabilitation hospital in US) and other selected providers across the US. It will be made more widely accessible in Q4 2021.
